TY - JOUR
T1 - Repetitive deep TMS for Parkinson disease
T2 - A 3-month double-blind, randomized sham-controlled study
AU - Cohen, Oren S.
AU - Rigbi, Amihai
AU - Yahalom, Gilad
AU - Warman-Alaluf, Naama
AU - Nitsan, Zeev
AU - Zangen, Abraham
AU - Hassin-Baer, Sharon
N1 - Publisher Copyright:
© 2018 by the American Clinical Neurophysiology Society.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Purpose: To study the effects of a repetitive deep transcranial magnetic stimulation (rDTMS) in patients with Parkinson disease using the H5 coil for the low-frequency stimulation of the primary motor cortex, followed by the high-frequency rDTMS of the prefrontal cortex. Methods: The main outcome measures were the total and motor scores of the Unified Parkinson's Disease Rating Scale (UPDRS). Secondary measures included rating of depression and quantitative motor tasks. Results: Forty-eight patients were randomized 1:1 into real or sham rDTMS treatment arms. Analyses (n = 42) of both UPDRS scores revealed a significant main effect for time between baseline and day 90 (end of treatment), indicating that there was an improvement of both scores over time in the whole sample. Although effects of treatment and time-by-treatment were insignificant, simple effects analysis of both measures was significant in the rDTMS group and reached a P-value of 0.06 in the sham group. The response rate was higher in patients with longer disease duration and higher motor UPDRS scores. Side effects were more common in the rDTMS group but were transient and tolerable. Conclusions: Although rDTMS treatment exhibited some motor improvements, we could not demonstrate an advantage for real treatment over sham. Further research is required to establish stimulation parameters that may induce potentially more beneficial outcomes, probably in patients with longer and more sever disease.
AB - Purpose: To study the effects of a repetitive deep transcranial magnetic stimulation (rDTMS) in patients with Parkinson disease using the H5 coil for the low-frequency stimulation of the primary motor cortex, followed by the high-frequency rDTMS of the prefrontal cortex. Methods: The main outcome measures were the total and motor scores of the Unified Parkinson's Disease Rating Scale (UPDRS). Secondary measures included rating of depression and quantitative motor tasks. Results: Forty-eight patients were randomized 1:1 into real or sham rDTMS treatment arms. Analyses (n = 42) of both UPDRS scores revealed a significant main effect for time between baseline and day 90 (end of treatment), indicating that there was an improvement of both scores over time in the whole sample. Although effects of treatment and time-by-treatment were insignificant, simple effects analysis of both measures was significant in the rDTMS group and reached a P-value of 0.06 in the sham group. The response rate was higher in patients with longer disease duration and higher motor UPDRS scores. Side effects were more common in the rDTMS group but were transient and tolerable. Conclusions: Although rDTMS treatment exhibited some motor improvements, we could not demonstrate an advantage for real treatment over sham. Further research is required to establish stimulation parameters that may induce potentially more beneficial outcomes, probably in patients with longer and more sever disease.
KW - H-coil
KW - Parkinson disease
KW - Repetitive deep TMS
KW - Transcranial magnetic stimulation
UR - http://www.scopus.com/inward/record.url?scp=85051870217&partnerID=8YFLogxK
U2 - 10.1097/WNP.0000000000000455
DO - 10.1097/WNP.0000000000000455
M3 - Article
C2 - 29373395
AN - SCOPUS:85051870217
SN - 0736-0258
VL - 35
SP - 159
EP - 165
JO - Journal of Clinical Neurophysiology
JF - Journal of Clinical Neurophysiology
IS - 2
ER -